Skip to main content
Top

09-04-2024 | Dynamic Hip Screw | Original Article

A retrospective chart analysis with 5-year follow-up of early care for geriatric hip fracture patients: why we should continue talking about hip fractures

Authors: An Sermon, Evelyne Verhulst, Laurens Aerden, Harm Hoekstra

Published in: European Journal of Trauma and Emergency Surgery

Login to get access

Abstract

Background

Timing of surgery remains a topic of debate for hip fracture treatment in the geriatric patient population. The quality indicator “early surgery” was implemented in 2014 at the Department of Trauma Surgery of the University Hospitals Leuven to enhance timely operative treatment. In this follow-up study, we aim to evaluate the performance of this quality indicator, the clinical outcomes, and room for improvement.

Methods

The charts of 1190 patients surgically treated for an acute hip fracture were reviewed between June 2017 and May 2022 at the University Hospitals Leuven. Primary endpoints were adherence to early surgery, defined as surgery within the next calendar day, and the evaluation of the reasons for deviating from this protocol. Secondary endpoints were length of stay (LOS); intensive care unit (ICU) admission and length of ICU stay; mortality after 30 days, 60 days, 90 days, and 6 months; and 90-day readmission rate. Pearson’s Chi-square test and Mann–Whitney U test were used for data analysis.

Results

One thousand eighty-four (91.1%) patients received early surgery versus 106 (8.9%) patients who received delayed surgery. The main reasons for surgical delay were the use of anticoagulants (33%), a general health condition not allowing safe surgery and/or existing comorbidities requiring workup prior to surgery (26.4%), and logistical reasons (17.9%). Patient delay and transfer from other hospitals were responsible for respectively 8.5% and 6.6% of delayed surgery. Early surgery resulted in a significantly shorter LOS and ICU stay (12 [8–25] vs. 18 [10–36] and 3 [2–6] vs. 7 [3–13] days, early vs. delayed surgery, respectively). No significant reduction was observed in ICU admission, mortality, and readmission rate.

Conclusion

We have been able to maintain the early surgery hip fracture protocol in approximately 90% of the patients. Comorbidities and anticoagulant use were responsible for delayed surgery in the majority of the patients. Correct implementation of the existing protocol on anticoagulant use could lead to a one-third decrease in the number of delayed surgeries. Subsequently, since the LOS and ICU stay in the delayed surgery group were significantly longer, a further increase of early surgery will lower the current economic burden.
Literature
1.
go back to reference Gullberg B, Johnell O, Kanis JA. World-wide projections for hip fracture. Osteoporos Int. 1997;7:407–13.CrossRefPubMed Gullberg B, Johnell O, Kanis JA. World-wide projections for hip fracture. Osteoporos Int. 1997;7:407–13.CrossRefPubMed
2.
go back to reference Deprey SM, Biedrzycki L, Klenz K. Identifying characteristics and outcomes that are associated with fall-related fatalities: multi-year retrospective summary of fall deaths in older adults from 2005–2012. Inj Epidemiol. 2017;4(1):21.CrossRefPubMedPubMedCentral Deprey SM, Biedrzycki L, Klenz K. Identifying characteristics and outcomes that are associated with fall-related fatalities: multi-year retrospective summary of fall deaths in older adults from 2005–2012. Inj Epidemiol. 2017;4(1):21.CrossRefPubMedPubMedCentral
3.
go back to reference Ekman E, Nurmi H, Reito A, et al. Complications following 250 cemented modular hip hemiarthroplasties. Scand J Surg. 2019;104:321–8.CrossRef Ekman E, Nurmi H, Reito A, et al. Complications following 250 cemented modular hip hemiarthroplasties. Scand J Surg. 2019;104:321–8.CrossRef
4.
go back to reference Librero J, Peiró S, Leutscher E, et al. Timing of surgery for hip fracture and in-hospital mortality: a retrospective population-based cohort study in the Spanish national health system. BMC Health Serv Res. 2012;12:15.CrossRefPubMedPubMedCentral Librero J, Peiró S, Leutscher E, et al. Timing of surgery for hip fracture and in-hospital mortality: a retrospective population-based cohort study in the Spanish national health system. BMC Health Serv Res. 2012;12:15.CrossRefPubMedPubMedCentral
5.
go back to reference Chiarello E, Tedesco G, Cadossi M, et al. Surgical prevention of femoral neck fractures in elderly osteoporotic patients: a literature review. Clin Cases Miner Bone Metab. 2016;13:42–5.PubMedPubMedCentral Chiarello E, Tedesco G, Cadossi M, et al. Surgical prevention of femoral neck fractures in elderly osteoporotic patients: a literature review. Clin Cases Miner Bone Metab. 2016;13:42–5.PubMedPubMedCentral
6.
go back to reference Librero J, Peiro S, Leutscher E, et al. Timing of surgery for hip fracture and in-hospital mortality: a retrospective population-based cohort study in the Spanish national health system. BMC Health Serv Res. 2012;12:15.CrossRefPubMedPubMedCentral Librero J, Peiro S, Leutscher E, et al. Timing of surgery for hip fracture and in-hospital mortality: a retrospective population-based cohort study in the Spanish national health system. BMC Health Serv Res. 2012;12:15.CrossRefPubMedPubMedCentral
7.
go back to reference Abrahamsen B, Van Staa T, Ariely R, et al. Excess mortality following hip fracture: a systematic epidemiological review. Osteoporos Int. 2009;20:1633–50.CrossRefPubMed Abrahamsen B, Van Staa T, Ariely R, et al. Excess mortality following hip fracture: a systematic epidemiological review. Osteoporos Int. 2009;20:1633–50.CrossRefPubMed
8.
go back to reference Neuman M, Silber J, Magaziner J, et al. Survival and functional outcomes after hip fracture among nursing home residents. JAMA Intern Med. 2014;174:1273–80.CrossRefPubMedPubMedCentral Neuman M, Silber J, Magaziner J, et al. Survival and functional outcomes after hip fracture among nursing home residents. JAMA Intern Med. 2014;174:1273–80.CrossRefPubMedPubMedCentral
11.
go back to reference NICE. Hip fracture: management, Clinical guideline [CG124]. 2014. NICE. Hip fracture: management, Clinical guideline [CG124]. 2014.
17.
go back to reference Sermon A, et al. The implementation of a clinical pathway enhancing early surgery for geriatric hip fractures: how to maintain a success story? Eur J Trauma Emerg Surg. 2019;45:199–205.CrossRefPubMed Sermon A, et al. The implementation of a clinical pathway enhancing early surgery for geriatric hip fractures: how to maintain a success story? Eur J Trauma Emerg Surg. 2019;45:199–205.CrossRefPubMed
18.
go back to reference Lieten S, et al. Analysis of the effects of a delay of surgery in patients with hip fractures: outcome and causes. Osteoporos Int. 2021;32:2235–45.CrossRefPubMed Lieten S, et al. Analysis of the effects of a delay of surgery in patients with hip fractures: outcome and causes. Osteoporos Int. 2021;32:2235–45.CrossRefPubMed
19.
go back to reference Kristan A, Omahen S, Tosounidis, et al. When does hip fracture surgery delay affects the length of hospital stay? Eur J Trauma Emerg Surg. 2019;45:701–8. Kristan A, Omahen S, Tosounidis, et al. When does hip fracture surgery delay affects the length of hospital stay? Eur J Trauma Emerg Surg. 2019;45:701–8.
20.
go back to reference Muller F, Galler M, Zellner M, et al. Total hip arthroplasty for hip fractures: time to surgery with respect to surgical revision, failure and mortality. Geriatr Orthop Surg Rehabil. 2019;10:2151459318818162.CrossRefPubMedPubMedCentral Muller F, Galler M, Zellner M, et al. Total hip arthroplasty for hip fractures: time to surgery with respect to surgical revision, failure and mortality. Geriatr Orthop Surg Rehabil. 2019;10:2151459318818162.CrossRefPubMedPubMedCentral
21.
go back to reference Kristan A, et al. Causes for delay of surgery in hip fractures and how it impacts on mortality – a single level 1 trauma center experience. ACHOT; 1/2021. Kristan A, et al. Causes for delay of surgery in hip fractures and how it impacts on mortality – a single level 1 trauma center experience. ACHOT; 1/2021.
22.
go back to reference Ryan DJ, Yoshihara H, Yoneoka D, et al. Delay in hip fracture surgery: an analysis of patient-specific and hospital-specific risk factors. J Orthop Trauma. 2015;29:343–8.CrossRefPubMed Ryan DJ, Yoshihara H, Yoneoka D, et al. Delay in hip fracture surgery: an analysis of patient-specific and hospital-specific risk factors. J Orthop Trauma. 2015;29:343–8.CrossRefPubMed
23.
go back to reference Siga T, Wajima Z, Ohe Y. Is operative delay associated with increased mortality of hip fracture patients? Systematic review, meta-analysis and meta-regression. Can J Anaesth. 2008;55:146–54.CrossRef Siga T, Wajima Z, Ohe Y. Is operative delay associated with increased mortality of hip fracture patients? Systematic review, meta-analysis and meta-regression. Can J Anaesth. 2008;55:146–54.CrossRef
24.
go back to reference Welford P, et al. The association between surgical fixation of hip fractures within 24 hours and mortality: a systematic review and meta-analysis. Bone JT J. 2021;103B:1176–86.CrossRef Welford P, et al. The association between surgical fixation of hip fractures within 24 hours and mortality: a systematic review and meta-analysis. Bone JT J. 2021;103B:1176–86.CrossRef
25.
go back to reference Lefaivre KA, et al. Length of stay, mortality, morbidity and delay to surgery in hip fractures. J Bone Joint Surg Br. 2009;91(7):922–7.CrossRefPubMed Lefaivre KA, et al. Length of stay, mortality, morbidity and delay to surgery in hip fractures. J Bone Joint Surg Br. 2009;91(7):922–7.CrossRefPubMed
26.
go back to reference HIP Attack Investigators. Accelerated surgery versus standard care in hip fracture: an international, randomized, controlled trial. Lancet. 2020;395:698–708.CrossRef HIP Attack Investigators. Accelerated surgery versus standard care in hip fracture: an international, randomized, controlled trial. Lancet. 2020;395:698–708.CrossRef
27.
go back to reference Lizaur-Utrilla A, Gonzalez-Navarro B, Vizcaya-Moreno MF, Miralles Muñoz FA, Gonzalez-Parreño S, Lopez-Prats FA. Reasons for delaying surgery following hip fractures and its impact on one year mortality. Int Orthop. 2019;43(2):441–8.CrossRefPubMed Lizaur-Utrilla A, Gonzalez-Navarro B, Vizcaya-Moreno MF, Miralles Muñoz FA, Gonzalez-Parreño S, Lopez-Prats FA. Reasons for delaying surgery following hip fractures and its impact on one year mortality. Int Orthop. 2019;43(2):441–8.CrossRefPubMed
28.
go back to reference Yaacobi, et al. Mortality following surgery for geriatric hip fractures: is it the timing or the co-morbidities? Hip Int. 2022;32(2):271–5.CrossRefPubMed Yaacobi, et al. Mortality following surgery for geriatric hip fractures: is it the timing or the co-morbidities? Hip Int. 2022;32(2):271–5.CrossRefPubMed
30.
go back to reference Steffel J, Verhamme P, Potpara TS, et al. The 2018 European Hearth Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Steffel J, Verhamme P, Potpara TS, et al. The 2018 European Hearth Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation.
32.
go back to reference Tamim H, Habbal M, Saliba A, et al. Preoperative INR and postoperative major bleeding and mortality: a retrospective cohort study. J Thromb Thrombolysis. 2016;41:301–11.CrossRefPubMed Tamim H, Habbal M, Saliba A, et al. Preoperative INR and postoperative major bleeding and mortality: a retrospective cohort study. J Thromb Thrombolysis. 2016;41:301–11.CrossRefPubMed
34.
go back to reference Connors J, et al. Idarucizumab (Praxbind) formulary review. Crit Pathw Cardiol. 2016;15(3):77–81.CrossRefPubMed Connors J, et al. Idarucizumab (Praxbind) formulary review. Crit Pathw Cardiol. 2016;15(3):77–81.CrossRefPubMed
35.
go back to reference Pollack C, Bernstein R, Dubiel R, et al. Healthcare resource utilization in patients receiving idarucizumab for reversal of dabigatran anticoagulation due to major bleeding, urgent surgery, or procedural interventions: interim results from the RE-VERSE AD study. J Med Econ. 2017;5:435–42.CrossRef Pollack C, Bernstein R, Dubiel R, et al. Healthcare resource utilization in patients receiving idarucizumab for reversal of dabigatran anticoagulation due to major bleeding, urgent surgery, or procedural interventions: interim results from the RE-VERSE AD study. J Med Econ. 2017;5:435–42.CrossRef
Metadata
Title
A retrospective chart analysis with 5-year follow-up of early care for geriatric hip fracture patients: why we should continue talking about hip fractures
Authors
An Sermon
Evelyne Verhulst
Laurens Aerden
Harm Hoekstra
Publication date
09-04-2024
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Trauma and Emergency Surgery
Print ISSN: 1863-9933
Electronic ISSN: 1863-9941
DOI
https://doi.org/10.1007/s00068-024-02514-x